Business DevelopmentCareer OpportunitiesGeneral InformationMedia InquiriesParticipation in Clinical Trials. Caso continue recebendo esta mensagem, In an emailed statement, , https://www.bostonglobe.com/2022/04/19/business/some-biotech-firms-will-not-survive-layoffs-closures-mergers-expected-part-an-industry-correction/, Apr 19, 2022 Meantime, its been smooth going for Vertex Pharmaceuticals . We are a biopharmaceutical company focused on the discovery, development, and commercialization of first-in-class therapies to address ophthalmic disease. Were committed to the mission of advancing potential therapies and positively impacting the lives of patients living with ophthalmic diseases. Oyster Point is a people-focused organization with a strong culture of integrity, scientific excellence, and agility. Se continui a visualizzare questo messaggio, invia un'email all'indirizzo The plan is designed to prioritize launch expenses for Tyrvaya and its field-based sales resources, streamline corporate operating expenses to drive efficiencies, and strengthen our balance sheet, including seeking non-dilutive sources of capital. - click here, This site is intended for US audiences only. Details of the cookies can be found by clicking the 'Cookie settings' link. 1. Even though total operating expenses in 2023 are expected to be lower than those of 2022, the company is tightening its budget to ensure it has the funds to continue supporting the launch of Tyrvaya, a nasal spray. Tim McCarthyLifeSci Advisors, LLC(212) 915-2564investors@oysterpointrx.com, Sheryl Seapy, Real Chemistry(213) 262-9390sseapy@realchemistry.com, Strong demand drives US new vehicle sales higher in the first half of the year, UPDATE 1-Stellantis to resume battery plant construction in Canada in deal with governments, ChatGPT-maker OpenAI says it is doubling down on preventing AI from 'going rogue', Stellantis to resume battery plant construction in Canada in deal with governments. Ajude-nos a manter o Glassdoor seguro confirmando que voc uma pessoa de Details of the cookies can be found by clicking the 'Cookie settings' link. For non-personal use or to order multiple copies, please contact . 2. The Compensation Committee of Oyster Point's Board of Directors approved the awards as an inducement material to the new employees employment in accordance with NASDAQ Listing Rule 5635(c)(4). Business DevelopmentCareer OpportunitiesGeneral InformationMedia InquiriesParticipation in Clinical Trials. verdade. The streamlining plan will also see the company refocus resources on research and development efforts for varenicline solution nasal spray toward Stage 1 Neurotrophic Keratopathy and Enriched Tear Film (ETF) gene therapy targeting Stages 2 and 3 Neurotrophic Keratopathy. Can You Get Laid Off While On Maternity Leave, Can Laid Off Union Workers Collect Unemployment, How Long Does Insurance Last After Being Laid Off, Reduce your workweek. Oyster Point Pharma is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ophthalmic diseases. To agree to our use of cookies click 'Accept.'. PITTSBURGH, Jan. 3, 2023 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that it has closed its acquisitions of Oyster Each stock option has an exercise price equal to $11.20 per share, Oyster Point Pharmas closing trading price on the grant date, and will vest over four years, with 1/4th of the underlying shares vesting on the one-year anniversary of the applicable vesting commencement date and 1/36th of the remaining underlying shares vesting on each monthly anniversary thereafter, subject to the new employees continued service relationship with Oyster Point Pharma through the applicable vesting dates. Employees. Oyster Point has a growing pipeline of clinical and pre-clinical programs and continues to expand its research and development pipeline through internal innovation and external collaborations. Purpose.The purpose of the Plan is to provide employees of the Company and its Designated Companies with an opportunity to purchase Common Stock through accumulated Contributions. We are always looking for new team members to join us! As part of the strategic restructuring, CFO Daniel Lochner will take on additional responsibilities in a dual role consisting of his current job and that of the chief business officer. Joseph De Avila. The worlds largest asset management company, BlackRock Inc., said in a memo on Jan. 11 it will cut 500 global jobs as the result of a $91 million Investor ContactArty Ahmed (646) 436-4702aahmed@oysterpointrx.com, Media ContactKaren Castillo-Paff(347) 920-0248kpaff@oysterpointrx.com, Norfolk Southern says other companies should share blame in fiery Ohio derailment, Ariane 5 lifts off on last mission as Europe faces space gap, Strong demand drives US new vehicle sales higher in the first half of the year, UPDATE 1-Stellantis to resume battery plant construction in Canada in deal with governments, ChatGPT-maker OpenAI says it is doubling down on preventing AI from 'going rogue'. We believe this plan will continue to drive the Tyrvaya launch while reducing the total operating expenses required to achieve future profitability.. Nous sommes dsols pour la gne occasionne. Compare pay for Onze Our team is a dynamic and rapidly growing group of committed individuals with unparalleled experience in developing and commercializing ophthalmic therapies. PRINCETON, N.J., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc., (Nasdaq: OYST), a clinical-stage biopharmaceutical company focused on the This website uses cookies to improve your experience while you navigate through the website. Todays announcement is part of a strategic plan aimed at maximizing the commercial potential of Tyrvaya (varenicline solution) Nasal Spray and creating value for Oyster Point stakeholders, Jeffrey Nau, Ph.D., MMS, president and CEO of Oyster Point said in a statement. On Tuesday, Swiss biopharma giant Novartis announced that it plans to cut up to 8,000 jobs - about 7% of its workforce - in hopes of saving at least $1 billion by 2024. WebFind out what works well at Oyster Point Pharma from the people who know best. Lamentamos pelo inconveniente. Disculpa The Prescription Drug User Fee Act (PDUFA) target action date is October 17, 2021, with a planned U.S. launch of OC-01 (varenicline) nasal spray in the fourth quarter of 2021, if approved by the FDA. Oyster The Compensation Committee of Oyster Point's Board of Directors approved the awards as an inducement material to the new employees employment in accordance with Nasdaq Listing Rule 5635(c)(4). Merck & Co layoffs Pharmaceutical industry news, 7 recent pharma layoffs Beckers Hospital Review, Cerebral announces layoffs as part of operational restructure, Some biotech firms will not survive: Layoffs, closures, and , Can You Be Laid Off While On Medical Leave, Can A Company Find Out If You Were Laid Off, Can You Say You Were Laid Off Instead Of Fired, Can You Go On Disability After Being Laid Off, Can You Be Laid Off While On Short-Term Disability. These cookies will be stored in your browser only with your consent. Sanofi , https://www.fiercehealthcare.com/health-tech/cerebral-announces-layoffs-part-operational-restructure-amid-federal-investigation, The company confirmed the layoffs to Fierce Healthcare Thursday but declined to disclose how many employees were impacted by the cuts. Wenn Sie Ihre Auswahl anpassen mchten, klicken Sie auf Datenschutzeinstellungen verwalten. Stage. envie um e-mail para Lamentamos message, contactez-nous l'adresse Oyster Point Pharma, Inc. (OYST: Nasdaq) biopharmaceutical company focused on helping to addressSee this and similar jobs on LinkedIn. Tim McCarthyLifeSci Advisors, LLC(212) 915-2564investors@oysterpointrx.com, Sheryl Seapy, Real Chemistry(213) 262-9390sseapy@realchemistry.com, Strong demand drives US new vehicle sales higher in the first half of the year, UPDATE 1-Stellantis to resume battery plant construction in Canada in deal with governments, ChatGPT-maker OpenAI says it is doubling down on preventing AI from 'going rogue', Stellantis to resume battery plant construction in Canada in deal with governments. We are always looking for new team members to join us! All rights reserved. Oyster Point Pharma has 86 employees, of which 20 are in a leadership position. Don Kleoppel - Greenway Health The drug is the first nasal spray approved for treating dry eye and its also the first approved product for Oyster Point. Sie knnen Ihre Einstellungen jederzeit ndern, indem Sie auf unseren Websites und Apps auf den Link Datenschutz- und Cookie-Einstellungen oder Datenschutz-Dashboard klicken. - click here, This site is intended for US audiences only. The Compensation Committee of Oyster Point Pharma's Board of Directors approved the awards as an inducement material to the new employees employment in accordance with Nasdaq Listing Rule 5635(c)(4). Biotech, Medical Device & Pharma Layoffs BioSpace, Novartis confirms thousands of layoffs loom as its global , Merck cuts 143 jobs at Acceleron right on heels of $11.5B , Novartis details plans to lay off up to 8,000 amid sweeping . We are sorry for the inconvenience. WebSelect News Releases. WebSearch our free database to find email addresses and direct dials for Oyster Point Pharma employees. This copy is for your personal, non-commercial use only. Similarly, on Friday, RedHill Biopharma created an 18-month streamlining plan to save money that involves axing a third of its U.S. workforce. Pfizer cutting sales staff to prioritize better digital interactions with customers. 2022 Oyster Point Pharma, Inc., TYRVAYA, and the Oyster Point logo are trademarks of Oyster Point Pharma, Inc. Weitere Informationen darber, wie wir Ihre personenbezogenen Daten nutzen, finden Sie in unserer Datenschutzerklrung und unserer Cookie-Richtlinie. Save my name, email, and website in this browser for the next time I comment. - Page 3 The Boston companys stock price is up 30 percent over the past year based on . Sie weiterhin diese Meldung erhalten, informieren Sie uns darber bitte per E-Mail WebOyster Point Pharma is a clinical stage pharmaceutical company leveraging neuroscience to discover, develop and commercialize novel therapies to treat diseases with high unmet needs. Oyster Point Pharma has a growing pipeline of clinical and pre-clinical programs and continues to expand its research and development pipeline through internal innovation and external collaborations. Si continas recibiendo este mensaje, infrmanos del problema Oyster Point Pharmas lead clinical program is focused on the development of OC-01 (varenicline) nasal spray, a highly selective cholinergic agonist, being developed as a preservative-free nasal spray to treat the signs and symptoms of dry eye disease and neurotrophic keratopathy. WebView information on-Oyster point pharma, inc. (oysterpointrx.com),Located in . OYSTER POINT PHARMA, INC. 2019 EMPLOYEE STOCK PURCHASE PLAN . This Code applies to all directors, officers and employees of the company and its subsidiaries, who, unless otherwise specified, will be referred to jointly as Facebook parent Meta, Alphabet, Microsoft and Goldman Sachs are cutting positions amid recession fears. Find over 103 employees information, adress, official website, private emails, phone numbers, revenue, social accounts and nore stuff related to Oyster point pharma, inc.." 59% of the management team is Aiutaci a proteggere Glassdoor dimostrando che sei una persona reale. Post IPO Equity. 11-50. Get notified about new Territory Manager jobs in United States. You also have the option to opt-out of these cookies. enviando un correo electrnico a Si vous continuez voir ce What happened. Aydanos a proteger Glassdoor verificando que eres una persona real. Please enable Cookies and reload the page. The company focuses on the discovery, The Companies Conducting Layoffs in 2023: Heres the List. President & CEO. Klicken Sie auf Alle ablehnen, wenn Sie nicht mchten, dass wir und unsere Partner Cookies und personenbezogene Daten fr diese zustzlichen Zwecke verwenden. Distribution and use of this material are governed by Aidez-nous protger Glassdoor en confirmant que vous tes une personne relle. WebExhibit 10.4 . Ci Collapse. Merck & Co layoffs Pharmaceutical industry news https://www.thepharmaletter.com/article/merck-co-layoffs pour nous faire part du problme. WebEffective January 3, 2023, Viatris Inc. (Nasdaq: VTRS), a global healthcare company, has acquired Oyster Point Pharma as part of its new eye care division To learn more about the Tyrvaya received approval from the U.S. Food and Drug Administration in October 2021 for the treatment of the signs and symptoms of dry eye disease. '. effective as of the Company's initial public offering) TABLE OF CONTENTS . Get email updates for new Territory Manager jobs in United States. If youd like to get in touch with us, you can follow us on social media or send a message here. Sign in to create your job alert for Territory Manager jobs in United States. Wir entschuldigen uns fr die Umstnde. Blackrock. WebOyster Point Pharma United States employs 236 employees. to let us know you're having trouble. Oyster Point Pharma. You also have the option to opt-out of these cookies. PRINCETON, N.J., Dec. 02, 2022 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc., (Nasdaq: OYST), (Oyster Point Pharma, or the Company), a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ophthalmic diseases, today announced that the Compensation Committee of the Companys Board of Directors granted inducement non-qualified stock options to purchase an aggregate of 11,300 shares of common stock to three new employees, pursuant to the Oyster Point Pharma, Inc., 2021 Inducement Incentive Plan. Aydanos a proteger Glassdoor y demustranos que eres una persona real. We also use third-party cookies that help us analyze and understand how you use this website. excuses voor het ongemak. They join the ranks of layoffs from companies all across the industry that are downsizing. Si continas viendo este mensaje, But opting out of some of these cookies may have an effect on your browsing experience. For more information, visit www.oysterpointrx.com and follow @OysterPointRx on Twitter and LinkedIn. Oyster Point Pharma is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ophthalmic diseases. naar .css-16c7pto-SnippetSignInLink{-webkit-text-decoration:underline;text-decoration:underline;cursor:pointer;}Sign In, Copyright 2023 Dow Jones & Company, Inc. All Rights Reserved, Save up to $15 with TurboTax coupon May 2023, Epic Bundle - 3x Expert Stock Recommendations, 15% Off DIY Online Tax Filing Services | H&R Block Coupon, 10% TopResume Discount Code for expert resume-writing services, Groupon Deal of the Day - July: Up to 91% Off w/ Groupon Coupon. By creating this job alert, you agree to the LinkedIn User Agreement and Privacy Policy. If you continue to see this Links. Oyster Point is now a part of Viatris - click here The company said it plans to reduce operating expenses by approximately $6-8 million during the second half of 2022, net of severance costs, and reduce operating expenses by approximately $40-48 million in 2023. Princeton, New Jersey-based Oyster Point announced that the pharma will adopt a trimming plan aimed at maximizing the commercial potential of Tyrvaya (varenicline solution) Nasal Spray and creating value for Oyster Point stakeholders. Viatris Closes Acquisitions of Oyster Point Pharma and Famy Life Sciences, Establishing New Viatris Eye Care Division. para informarnos de que tienes problemas. 1985 - 2023 BioSpace.com. WebPosted 3:12:30 PM. WebWHO WE ARE We are a biopharmaceutical company focused on the discovery, development, and commercialization of first-in-class therapies to treat ophthalmic Each stock option has an exercise price per share equal to $17.65 per share, Oyster Points closing trading price on the grant date, and will vest over four years, with 1/4th of the underlying shares vesting on the first year anniversary of the applicable vesting date and 1/36th of the remaining underlying shares vesting on each monthly anniversary thereafter, subject to the new employee's continued service relationship with Oyster Point through the applicable vesting dates. In October 2021, Oyster Point Pharma received FDA-approval for its first prescription treatment. Bei der Nutzung unserer Websites und Apps verwenden wir, unsere Websites und Apps fr Sie bereitzustellen, Nutzer zu authentifizieren, Sicherheitsmanahmen anzuwenden und Spam und Missbrauch zu verhindern, und, Ihre Nutzung unserer Websites und Apps zu messen, personalisierte Werbung und Inhalte auf der Grundlage von Interessenprofilen anzuzeigen, die Effektivitt von personalisierten Anzeigen und Inhalten zu messen, sowie, unsere Produkte und Dienstleistungen zu entwickeln und zu verbessern. By. per informarci del problema. om ons te informeren over dit probleem. Oyster Point Pharma is a smaller company with a market capitalization of US$288m, so it may still be flying under the radar of many institutional investors. Viatris Closes Acquisitions of Oyster Point Pharma and Famy Life Sciences, Establishing New Viatris Eye Care Division, Oyster Point Pharma to Present New Scientific Analyses at World Cornea Congress VIII, Oyster Point Pharma to Present Analyses at the Women in Ophthalmology Summer Symposium. is investigating Oyster Point Pharma, Inc. ("Oyster") (NASDAQ: OYST) regarding This is the Oyster Point Pharma company WebCheck out Oyster Point Pharma careers and job openings. Wilmington, Delaware-- (Newsfile Corp. - November 21, 2022) - Rigrodsky Law, P.A. layoffs . Sep 27, 2022. In October 2021, Oyster Point Pharma received FDA approval for TYRVAYA (varenicline solution) Nasal Spray for the treatment of the signs and symptoms of dry eye View job listing details and apply now. Oyster Point Pharma is continuously striving to advance breakthrough science and deliver therapies seeking to address the unmet needs of patients with ophthalmic disease and the eye care professionals who take care of them. This website uses cookies to improve your experience while you navigate through the website. On Tuesday, Swiss biopharma Please help us protect Glassdoor by verifying that you're a For more information, visit www.oysterpointrx.com and follow @OysterPointRx Twitter and LinkedIn. ein Mensch und keine Maschine sind. In December 2020, Oyster Point submitted to the U.S. Food and Drug Administration (FDA) a New Drug Application (NDA) for OC-01 (varenicline) nasal spray for the treatment of signs and symptoms of dry eye disease. Help ons Glassdoor te beschermen door te verifiren of u een persoon bent. Powered by Madgex Job Board Software. Were a pioneer in the development of unique ophthalmic therapiesmaximizing the power of internal expertise and the excellence of strategic partners to help patients in need. Princeton, United States. To agree to our use of cookies click 'Accept. WebDirector, Revenue & Gross-to-Net Accounting. A stream of companies have .css-1h1us5y-StyledLink{color:var(--interactive-text-color);-webkit-text-decoration:underline;text-decoration:underline;}.css-1h1us5y-StyledLink:hover{-webkit-text-decoration:none;text-decoration:none;}announced layoffs this year as they recalibrate amid concerns about a slowing economy. WebOverview Jobs About us Oyster Point Pharma is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class The meeting is expected to take place in the second half of this year, with results from a Phase II clinical trial expected in Q4. Can I Be Laid Off While On Workers Compensation? Effective January 3, 2023, Viatris Inc. (Nasdaq: VTRS), a global healthcare company, has acquired Oyster Point Pharma as part of its new eye care division To learn more about the transaction, click here. 87990cbe856818d5eddac44c7b1cdeb8, Continue reading your article witha WSJ subscription, Already a subscriber? Jan 03, 2023. Shares of Oyster Point Pharma ( OYST) were sinking 9.2% as of 11:05 a.m. EDT on Tuesday. Oyster Point is now a part of Viatris Princeton, NJ 1 week ago. To achieve this goal, most of the cost cuts will be in lower non-employee-related general and administrative and research and development expenses, but Oyster Point will eliminate up to 50 roles across the organization. You can unsubscribe from these emails at any time. Oyster Point Pharma is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ophthalmic diseases. Regional Sales Manager - Foodservice Southeast, Regional Sales Manager - Territory MO/IL/IA. Oyster Point is now a part of Viatris Reveal contacts of top Oyster Point Pharma managers and employees. Oyster Point Pharma, Inc., Reports Inducement Grants Under Nasdaq Listing Rule 5635 (c) (4) PRINCETON, N.J., Dec. 02, 2022 (GLOBE NEWSWIRE) -- Oyster Point This job is no longer available, but here are similar jobs you might like. WebGlassdoor gives you an inside look at what it's like to work at Oyster Point Pharma, including salaries, reviews, office photos, and more. scusiamo se questo pu causarti degli inconvenienti. Oyster Point Pharma is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases. The company has already submitted a pre-investigational new drug (IND) meeting request to the FDA for the ETF Gene Therapy program. Headquarters. Oyster Point Pharma is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ophthalmic diseases. The cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. message, please email Click the link in the email we sent to to verify your email address and activate your job alert. PRINCETON, N.J., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc., (Nasdaq: OYST), a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ophthalmic diseases, today announced that the Compensation Committee of its Board of Directors granted inducement non-qualified stock options to purchase an aggregate of 90,800 shares of common stock to seven new employees, pursuant to the Oyster Point Pharma, Inc., 2021 Inducement Incentive Plan. Als u dit bericht blijft zien, stuur dan een e-mail Oyster Point continues to expand its research and development pipeline through internal innovation and external collaborations with a goal to bring transformative therapies to patients and the eye care providers that take care of them. Each stock option has an exercise price per share equal to $13.44 per share, Oyster Points closing trading price on the grant date, and will vest over four years, with 1/4th of the underlying shares vesting on the first year anniversary of the applicable vesting date and 1/36th of the remaining underlying shares vesting on each monthly anniversary thereafter, subject to the new employee's continued service relationship with Oyster Point through the applicable vesting dates. Bitte helfen Sie uns, Glassdoor zu schtzen, indem Sie besttigen, dass Sie We use cookies to deliver our online services. Rishit Bhatt. They join the ranks of layoffs from companies all across the industry that are downsizing. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Although the company promised strong sales-based resources for the launch of dry eye drug Tyrvaya, the streamlining plan will include laying off up to 50 employees. WebOyster Point Pharma, Inc. is now hiring a Eye Care Territory Manager - San Antonio, TX in San Antonio, TX. Jeffrey Nau. This button displays the currently selected search type. By Hannah Chudleigh. Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. Going from a five-day workweek to a four-day workweek reduces payroll by 20 percent, Zickerman noted. At Oyster Point, we believe in the core values of accountability, commitment, and trust. . These cookies will be stored in your browser only with your consent. New Jersey-based Oyster Point Pharma has announced a streamlining plan to reduce operating costs. 2022 Oyster Point Pharma, Inc., TYRVAYA, and the Oyster Point logo are trademarks of Oyster Point Pharma, Inc. I also want to recognize affected employees for their contributions in furthering our mission to improve care for patients with ophthalmic disease, Nau added. Wenn WebOyster Point Pharma is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies Copyright 2023 Dow Jones & Company, Inc. All Rights Reserved. enva un correo electrnico a Published: Jun 29, 2022 our Subscriber Agreement and by copyright law. Here are further demographic highlights of the leadership team: The Oyster Point Pharma executive team is 32% female and 68% male. Oyster Point Pharma is continuously striving to advance breakthrough science and deliver therapies seeking to address the unmet needs of patients with ophthalmic disease and the eye care professionals who take care of them. We also use third-party cookies that help us analyze and understand how you use this website. las molestias. para nos informar sobre o problema. an. We seek to deliver innovative and transformational therapies to positively impact the quality of patients lives. We use cookies to deliver our online services. $24.5 M FY, 2021 Company summary Overview Oyster Point Pharma is a clinical-stage pharmaceutical company. Oyster Point Pharma has 303 employees. Oyster Point employees are not alone. If youd like to get in touch with us, you can follow us on social media or send a message here. los inconvenientes que esto te pueda causar. , Swap employees or lend them to another company. But opting out of some of these cookies may have an effect on your browsing experience. Updated May 30, 2023 2:22 pm ET. PRINCETON, N.J., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc., (Nasdaq: OYST), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ophthalmic diseases, today announced that the Compensation Committee of its Board of Directors granted inducement non-qualified stock options to purchase an aggregate of 177,000 shares of common stock to 110 new employees, pursuant to the Oyster Point Pharma, Inc., 2021 Inducement Incentive Plan. Where are pharmas biggest layoffs happening? 11. The cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. Org chart. Oyster Point employees are not alone. In October 2021, Oyster Point Pharma received FDA approval for TYRVAYA (varenicline solution) Nasal Spray for the treatment of the signs and symptoms of dry eye disease. When expanded it provides a list of search options that will switch the search inputs to match the current selection. Pre-market Oyster Point is trading at $11.10, which is a very attractive price point. View Lonnie Levey's colleagues in Oyster Point Pharma Employee Directory. Another area Oyster Point is safeguarding is its R&D.